Massachusetts Financial Services Co. MA Has $230.78 Million Stock Position in The Cooper Companies, Inc. $COO

Key Points

• Massachusetts Financial Services Co. trimmed its stake in The Cooper Companies by 9.2% in Q4 to 2,815,806 shares worth $230.78 million, about 1.44% of the company.
• Other major funds added to positions — notably Capital World Investors (10.55M shares, ~$723M) and Wellington Management (up 332.9% to 6.18M shares) — leaving institutional/hedge ownership at roughly 24.39%.
• Analysts' consensus is a "Moderate Buy" with an average price target of $90.79; Cooper beat quarterly EPS estimates but the stock trades below its 50- and 200-day moving averages and has a P/E near 35, creating short-term downside sensitivity.

Massachusetts Financial Services Co. MA reduced its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 9.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 2,815,806 shares of the medical device company's stock after selling 283,944 shares during the quarter. Massachusetts Financial Services Co. MA owned approximately 1.44% of Cooper Companies worth $230,783,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Capital World Investors increased its position in Cooper Companies by 25.7% in the 3rd quarter. Capital World Investors now owns 10,551,592 shares of the medical device company's stock valued at $723,417,000 after acquiring an additional 2,159,233 shares during the period. State Street Corp increased its position in Cooper Companies by 1.2% in the 2nd quarter. State Street Corp now owns 8,659,741 shares of the medical device company's stock valued at $616,227,000 after acquiring an additional 104,910 shares during the period. Wellington Management Group LLP increased its position in Cooper Companies by 332.9% in the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company's stock valued at $424,043,000 after acquiring an additional 4,756,178 shares during the period. Sustainable Growth Advisers LP increased its position in Cooper Companies by 22.1% in the 3rd quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company's stock valued at $283,327,000 after acquiring an additional 747,476 shares during the period. Finally, Ameriprise Financial Inc. increased its position in Cooper Companies by 98.8% in the 2nd quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company's stock valued at $241,120,000 after acquiring an additional 1,683,561 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on COO shares. Needham & Company LLC upped their price target on shares of Cooper Companies from $99.00 to $101.00 and gave the company a "buy" rating in a research report on Friday, March 6th. The Goldman Sachs Group reiterated a "sell" rating and set a $73.00 price objective on shares of Cooper Companies in a research report on Friday, January 9th. Rothschild & Co Redburn cut shares of Cooper Companies from a "buy" rating to a "neutral" rating and set a $85.00 price objective for the company. in a research report on Wednesday, March 4th. Barclays increased their price objective on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, March 6th. Finally, Citigroup decreased their price objective on shares of Cooper Companies from $88.00 to $87.00 and set a "neutral" rating for the company in a research report on Friday, March 6th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $90.79.

Key Cooper Companies News

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: CooperVision launched the "MADE BETTER™ Promise," a global sustainability platform focused on responsible sourcing, more efficient manufacturing and partial plastic-footprint offsets. This enhances Cooper's ESG profile and brand positioning in contact lenses, which can support long-term customer and investor sentiment even if near-term revenue impact is limited. CooperVision Launches MADE BETTER™ Promise
• Neutral Sentiment: Short-interest report shows an anomalous spike entry but lists 0 shares and NaN change, with a days-to-cover of 0.0 — this appears to be a data/reporting glitch rather than evidence of meaningful new short pressure or a short-squeeze setup. Investors should wait for corrected reporting before reacting.
• Negative Sentiment: Technical and liquidity factors likely weighing on the stock: COO is trading below its 50- and 200-day moving averages (~$76.89 / $76.35), volume today is below average, and valuation (P/E ~35) leaves the stock sensitive to profit-taking or broader market/healthcare sector weakness. Those dynamics can drive short-term downside despite solid recent results.

Cooper Companies Stock Performance

COO opened at $71.21 on Monday. The Cooper Companies, Inc. has a twelve month low of $61.78 and a twelve month high of $89.83. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. The company has a fifty day moving average of $76.69 and a 200-day moving average of $76.49. The stock has a market cap of $13.89 billion, a PE ratio of 35.25, a price-to-earnings-growth ratio of 1.84 and a beta of 1.07.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.03 by $0.07. The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. Cooper Companies's revenue for the quarter was up 6.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.